Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone versus dexmedetomidine as adjuvants to bupivacaine in iliopsoas plane block for hip surgery
PACTR202402718826002Phase 3Recruiting
- Sponsor
- Mansoura University Faculty of Medicine
- Start
- Feb 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of bupivacaine, dexamethasone and dexmedetomidine in pain (3 arms), sponsored by Mansoura University Faculty of Medicine. Primary endpoint: duration of analgesia. Started Feb 2024; status: recruiting.
02
Drugs
bupivacainedexamethasonedexmedetomidine
03
Conditions
pain
Beyond the preview
Go deeper on PACTR202402718826002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202402718826002.